210
panel
(Parent Session Title Will Not Publish to Web)
panel
Health Heroes Placeholder
panel
Future Pathways to Enable Open Science and Increase Research Transparency and Collaboration
Despite the billions of dollars invested in biomedical R&D, there remains a lack of transpar
ency concerning research findings that do not demonstrate efficacy, never reach completion, or remain behind paywalls. The federal government has issued guid
+ Read More
panel
Shooting for the Moon: Embracing Moonshot Philanthropy to Revolutionize Human Health
Facing any number of seemingly intractable challenges in global health—from rare diseases to inf
ectious outbreaks—philanthropists and multisector collaborators more than ever have a critical role to play.
+ Read More
panel
Part 2: The Next Century of Health: Predictions on the Future of Health Care
Technology is evolving at an unprecedented rate, enabling the rapid development of vaccines, AI-
driven treatment pathways, medical devices that can track your personal health and medications delivered by drones.
+ Read More
panel
Community-Based Research Collaboratory Roundtable (Invite only)
This session brings together participants and advisors to a new consortium, the Community-Based
Research Collaboratory, to be convened by FasterCures in 2024 with support from the Heritage Provider Network.
+ Read More
panel
Cell and Gene Therapies: How Will We Pay for It? (Invite only)
The advent of cell and gene therapies has brought unprecedented breakthroughs in the field of me
dicine, offering hope for previously untreatable diseases.
+ Read More
panel
Bringing Health Research Closer to Communities
The population of trusted intermediaries for health information, research engagement, and servic
es is shifting.
+ Read More
panel
Defining the Value of Patient Engagement for Medical Device and Digital Health Innovators (Invite only)
During the past decade, considerable progress has been made toward integrating patient perspecti
ves and input into biomedical research, as evidenced by the proliferation of legislation, regulatory guidance, and resources aimed at expanding patient-centr
+ Read More
panel
New Approaches to Drug Development: Is the Public Onboard? (Invite only)
Randomized clinical trials have long been held as the evidentiary standard for determining safet
y and efficacy for medical products.
+ Read More
panel